Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer. (27th August 2020)

• Record Type: Journal Article
• Authors: Darst, Burcu F; Dadaev, Tokhir; Saunders, Ed; Sheng, Xin; Wan, Peggy; Pooler, Loreall; Xia, Lucy Y; Chanock, Stephen; Berndt, Sonja I; Gapstur, Susan M; Stevens, Victoria; Albanes, Demetrius; Weinstein, Stephanie J; Gnanapragasam, Vincent; Giles, Graham G; Nguyen-Dumont, Tu; Milne, Roger L; Pomerantz, Mark; Schmidt, Julie A; Mucci, Lorelei; Catalona, William J; Hetrick, Kurt N; Doheny, Kimberly F; MacInnis, Robert J; Southey, Melissa C; Eeles, Rosalind A; Wiklund, Fredrik; Kote-Jarai, Zsofia; Conti, David V; Haiman, Christopher A
• Is Part Of: Journal of the National Cancer Institute. Volume 113:Number 5(2021)
• Page Start: 616
• Page End: 625
• Publication Date: 2020-08-27
• Subjects: Cancer -- Periodicals; Cancer -- Research -- Periodicals; 616.994
• DOI: 10.1093/jnci/djaa132
• Languages: English
• ISSNs: 0027-8874

Abstract

Abstract: Background: There is an urgent need to identify factors specifically associated with aggressive prostate cancer (PCa) risk. We investigated whether rare pathogenic, likely pathogenic, or deleterious (P/LP/D) germline variants in DNA repair genes are associated with aggressive PCa risk in a case-case study of aggressive vs nonaggressive disease. Methods: Participants were 5545 European-ancestry men, including 2775 nonaggressive and 2770 aggressive PCa cases, which included 467 metastatic cases (16.9%). Samples were assembled from 12 international studies and germline sequenced together. Rare (minor allele frequency < 0.01) P/LP/D variants were analyzed for 155 DNA repair genes. We compared single variant, gene-based, and DNA repair pathway-based burdens by disease aggressiveness. All statistical tests are 2-sided. Results: BRCA2 and PALB2 had the most statistically significant gene-based associations, with 2.5% of aggressive and 0.8% of nonaggressive cases carrying P/LP/D BRCA2 alleles (odds ratio [OR] = 3.19, 95% confidence interval [CI] = 1.94 to 5.25, P = 8.58 × 10 -7 ) and 0.65% of aggressive and 0.11% of nonaggressive cases carrying P/LP/D PALB2 alleles (OR = 6.31, 95% CI = 1.83 to 21.68, P = 4.79 × 10 -4 ). ATM had a nominal association, with 1.6% of aggressive and 0.8% of nonaggressive cases carrying P/LP/D ATM alleles (OR = 1.88, 95% CI = 1.10 to 3.22, P = .02). In aggregate, P/LP/D alleles within 24 literature-curated candidate PCa DNA repair genes were more common in aggressive than nonaggressive cases (carrier frequencies = 14.2% vs 10.6%, respectively; P = 5.56 × 10 -5 ). However, this difference was non-statistically significant ( P = .18) on excluding BRCA2, PALB2, and ATM . Among these 24 genes, P/LP/D carriers had a 1.06-year younger diagnosis age (95% CI = -1.65 to 0.48, P = 3.71 × 10 -4 ). Conclusions: Risk conveyed by DNA repair genes is largely driven by rare P/LP/D alleles within BRCA2, PALB2, and ATM . These findings support the importance of these genes in both screening and disease management considerations.